MF
KRTX

Magnetar Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Magnetar Financial’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-202,165
Closed -$64M – 517
2023
Q4 		$64M Buy
202,165
+198,264
+5,082% +$38.5M 1.62% 14
2023
Q3 		$660K Buy
3,901
+1,161
+42% +$218K 0.02% 295
2023
Q2 		$594K Sell
2,740
-1,109
-29% -$238K 0.01% 324
2023
Q1 		$699K Sell
3,849
-719
-16% -$138K 0.01% 427
2022
Q4 		$898K Sell
4,568
-1,782
-28% -$382K 0.02% 543
2022
Q3 		$1.43M Buy
6,350
+3,217
+103% +$651K 0.02% 653
2022
Q2 		$396 Buy
+3,133
New +$360K ﹤0.01% 1196

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Magnetar Financial's KRTX Position: Q1 2024 in Review

Magnetar Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 202,165 shares — an estimated $64M sold.

Magnetar Financial first reported a position in KRTX in Q2 2022 and held it in 7 quarters. The position peaked at $64M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Magnetar Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Magnetar Financial sold 202,165 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $64M.
  • Magnetar Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Magnetar Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $64M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Magnetar Financial's 13F filing for Q1 2024, filed 15 May 2024.